Healthcare disparities, screening, and molecular testing in the changing landscape of non–small cell lung cancer in the United States: a review
2024 · Cancer and Metastasis Reviews · 11 citations
https://doi.org/10.1007/s10555-024-10187-6
N
Narjust Florez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
106
Citations
7
h-index
4
i10-index
Narjust Florez is an academic researcher from Harvard University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Diversity and Career in Medicine & Lung Cancer Diagnosis and Treatment. The author has an h-index of 7, co-authored 34 publications.
ORCID: 0009-0004-0806-6722Papers by this author
worksLung cancer screening among minority groups: Identifying gaps in screening and opportunities for intervention
2024 · JTCVS Open · 5 citations
https://doi.org/10.1016/j.xjon.2024.07.001
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024
2025 · Cancer · 1 citations
https://doi.org/10.1002/cncr.70060
The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for EGFR-Mutated Non-Small Cell Lung Cancer: a Vodcast
2025 · Oncology and Therapy · 1 citations
https://doi.org/10.1007/s40487-025-00386-8
Understanding the experience of Latinas in medical education: A qualitative study
2025 · Cancer · 0 citations
https://doi.org/10.1002/cncr.35700
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat